← All organizations
Highest phase reached
Phase 3
First clinical trial
Mar 1, 2001Last known activity
May 25, 2017
Timeline
No events for the selected filters.
Drugs by trial phase (5 distinct, 3 trials)
Phase 3 (3 own, 0 via acquisition)
Phase 2 (2 own, 0 via acquisition)
Indications
Recent trials (3)
- NCT02955082CollaboratorPhase 2May 25, 2017
- NCT01416493Overall official - principal investigatorPhase 1/Phase 2May 1, 2011
- NCT00025090Study chairPhase 3Mar 1, 2001
Details
- Last known activity
- May 25, 2017